申请人:Campiani Giuseppe
公开号:US20090238761A1
公开(公告)日:2009-09-24
This invention provides novel aryl piperazine derivatives having medical utility, in particular as modulators of dopamine and serotonin receptors, preferably the D
3
, D
2
-like and 5-HT
2
receptor subtypes, and in particular useful for the treatment of neuropsychiatric disorders incl. schizophrenia.
这项发明提供了具有医疗效用的新型芳基哌嗪衍生物,特别是作为多巴胺和5-羟色胺受体的调节剂,优选为D3、D2样和5-HT2受体亚型,特别适用于治疗包括精神分裂症在内的神经精神障碍。